These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38282613)

  • 1. Functional characterization of
    Won JY; Mazigo E; Cha SH; Han JH
    Front Cell Infect Microbiol; 2023; 13():1321240. PubMed ID: 38282613
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
    Joet T; Eckstein-Ludwig U; Morin C; Krishna S
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum.
    Jiang X; Yuan Y; Huang J; Zhang S; Luo S; Wang N; Pu D; Zhao N; Tang Q; Hirata K; Yang X; Jiao Y; Sakata-Kato T; Wu JW; Yan C; Kato N; Yin H; Yan N
    Cell; 2020 Oct; 183(1):258-268.e12. PubMed ID: 32860739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
    Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
    Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hexose transporter of Plasmodium falciparum is a worthy drug target.
    Joët T; Krishna S
    Acta Trop; 2004 Feb; 89(3):371-4. PubMed ID: 14744563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes.
    Woodrow CJ; Burchmore RJ; Krishna S
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9931-6. PubMed ID: 10954735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs.
    Blume M; Hliscs M; Rodriguez-Contreras D; Sanchez M; Landfear S; Lucius R; Matuschewski K; Gupta N
    FASEB J; 2011 Apr; 25(4):1218-29. PubMed ID: 21169382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor.
    Joët T; Chotivanich K; Silamut K; Patel AP; Morin C; Krishna S
    Biochem J; 2004 Aug; 381(Pt 3):905-9. PubMed ID: 15107012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An
    Altharawi A; Riadi Y; Tahir Ul Qamar M
    J Biomol Struct Dyn; 2023; 41(23):14450-14459. PubMed ID: 36812293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the Plasmodium falciparum hexose transporter and its therapeutic interventions.
    Jiang X
    Proteins; 2022 Oct; 90(10):1766-1778. PubMed ID: 35445447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality.
    Slavic K; Straschil U; Reininger L; Doerig C; Morin C; Tewari R; Krishna S
    Mol Microbiol; 2010 Mar; 75(6):1402-13. PubMed ID: 20132450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK malaria treatment guidelines 2016.
    Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
    J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthosteric-allosteric dual inhibitors of PfHT1 as selective antimalarial agents.
    Huang J; Yuan Y; Zhao N; Pu D; Tang Q; Zhang S; Luo S; Yang X; Wang N; Xiao Y; Zhang T; Liu Z; Sakata-Kato T; Jiang X; Kato N; Yan N; Yin H
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33402433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family.
    Joët T; Holterman L; Stedman TT; Kocken CH; Van Der Wel A; Thomas AW; Krishna S
    Biochem J; 2002 Dec; 368(Pt 3):923-9. PubMed ID: 12238947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter.
    Woodrow CJ; Penny JI; Krishna S
    J Biol Chem; 1999 Mar; 274(11):7272-7. PubMed ID: 10066789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of parasite transporters in Xenopus oocytes.
    Krishna S; Woodrow CJ
    Novartis Found Symp; 1999; 226():126-39; discussion 139-44. PubMed ID: 10645543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the hexose transporter of Plasmodium falciparum and development of a three-dimensional model.
    Manning SK; Woodrow C; Zuniga FA; Iserovich P; Fischbarg J; Louw AI; Krishna S
    J Biol Chem; 2002 Aug; 277(34):30942-9. PubMed ID: 12042321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography and magnetic resonance imaging in experimental human malaria to identify organ-specific changes in morphology and glucose metabolism: A prospective cohort study.
    Woodford J; Gillman A; Jenvey P; Roberts J; Woolley S; Barber BE; Fernandez M; Rose S; Thomas P; Anstey NM; McCarthy JS
    PLoS Med; 2021 May; 18(5):e1003567. PubMed ID: 34038421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of an Anopheline midgut GPI-anchored protein in mediating Plasmodium falciparum and Plasmodium vivax ookinete invasion.
    Mathias DK; Jardim JG; Parish LA; Armistead JS; Trinh HV; Kumpitak C; Sattabongkot J; Dinglasan RR
    Infect Genet Evol; 2014 Dec; 28():635-47. PubMed ID: 24929123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.